We bring you our Wednesday Weekly FDA Product Recalls Report. Surprisingly there were no new recalls initiated by Indian Pharmacos over the last 7 days ...
Drug major Lupin has initiated a recall of Escitalopram Tablets manufactured at its Goa facility (ANDA approcal received in September, 2012) which is a generic ...
Drug major Sun Pharmaceutical Industries Inc. (the US subsidiary of Sun Pharma), initiated a nationwide recall of its Carvedilol Tablets used in the treatment ...
Drug major Lupin Limited has initiated a recall of 55,348 bottles of Amlodipine Besylate Tablets. This recall has been initiated for the manufacturing ...
Cadila Healthcare – the 4th largest player in the Indian pharma market with 16 of the group’s brands feature amongst the top 300 pharma brands in India as ...
Piramal Enterprises US subsidiary has sealed the deal to acquire US based active pharmaceutical ingredient manufacturing (API) firm Ash Stevens Inc for $52.95 ...
Lupin had a good numbers in terms of sales i.e 41% growth QoQ. The net profits saw a growth of 56% QoQ. Key Takeaways: Operating Margin went up from 22.92% ...
Pharma Major Lupin Limited (Lupin) announced that its Japanese subsidiary Kyowa Pharmaceutical has entered into a strategic asset purchase agreement with ...
